19 Recruiting B Acute Lymphoblastic Leukemia Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for B Acute Lymphoblastic Leukemia
Related Conditions
Top Recruiting B Acute Lymphoblastic Leukemia Studies
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
View Study & Checklist ➔Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies
📍 Stanford University, School of Medicine — Palo Alto, California
View Study & Checklist ➔CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia
📍 OHSU Knight Cancer Institute — Portland, Oregon
View Study & Checklist ➔Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔